{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:03:21Z","timestamp":1779800601197,"version":"3.53.1"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00203-026-04787-9","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T03:53:28Z","timestamp":1771818808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SFTSV: a priority pathogen in need of a cure-reviewing the therapeutic"],"prefix":"10.1007","volume":"208","author":[{"given":"Radhwan Abdul","family":"Kareem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder Naji","family":"Sameer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab H.","family":"Athab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaned","family":"Adil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Hassan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"4787_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2024.105613","volume":"122","author":"M Aghajani Mir","year":"2024","unstructured":"Aghajani Mir M (2024) Illuminating the pathogenic role of SARS-CoV-2: insights into competing endogenous RNAs (ceRNAs) regulatory networks. Infect Genet Evol 122:105613. https:\/\/doi.org\/10.1016\/j.meegid.2024.105613","journal-title":"Infect Genet Evol"},{"key":"4787_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/2040206617740303","volume":"25","author":"M Baba","year":"2017","unstructured":"Baba M, Toyama M, Sakakibara N, Okamoto M, Arima N, Saijo M (2017) Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors. Antivir Chem Chemother 25:83\u201389. https:\/\/doi.org\/10.1177\/2040206617740303","journal-title":"Antivir Chem Chemother"},{"key":"4787_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00257-5","volume":"5","author":"NE Bopp","year":"2020","unstructured":"Bopp NE et al (2020) Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development. NPJ Vaccines 5:111","journal-title":"NPJ Vaccines"},{"key":"4787_CR4","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1016\/j.csbj.2021.09.034","volume":"19","author":"J Cao","year":"2021","unstructured":"Cao J et al (2021) Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targets. Comput Struct Biotechnol J 19:5568\u20135577. https:\/\/doi.org\/10.1016\/j.csbj.2021.09.034","journal-title":"Comput Struct Biotechnol J"},{"key":"4787_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","volume":"53","author":"MA Casel","year":"2021","unstructured":"Casel MA, Park SJ, Choi YK (2021) Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy. Exp Mol Med 53:713\u2013722","journal-title":"Exp Mol Med"},{"key":"4787_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01298-4","volume":"10","author":"I Cha","year":"2025","unstructured":"Cha I et al (2025) A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination. NPJ Vaccines 10:248","journal-title":"NPJ Vaccines"},{"key":"4787_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-024-13135-0","volume":"108","author":"Y-C Chang","year":"2024","unstructured":"Chang Y-C et al (2024a) Gn protein expressed in plants for diagnosis of severe fever with thrombocytopenia syndrome virus. Appl Microbiol Biotechnol 108:303. https:\/\/doi.org\/10.1007\/s00253-024-13135-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"4787_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2400163121","volume":"121","author":"Z Chang","year":"2024","unstructured":"Chang Z et al (2024b) Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model. Proc Natl Acad Sci U S A 121:e2400163121. https:\/\/doi.org\/10.1073\/pnas.2400163121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4787_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2022.108291","volume":"117","author":"D Chaudhuri","year":"2022","unstructured":"Chaudhuri D, Datta J, Majumder S, Giri K (2022) In silico study on miRNA regulation and NSs protein interactome characterization of the SFTS virus. J Mol Graph Model 117:108291. https:\/\/doi.org\/10.1016\/j.jmgm.2022.108291","journal-title":"J Mol Graph Model"},{"key":"4787_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/immuno2010012","volume":"2","author":"K Chawla","year":"2022","unstructured":"Chawla K et al (2022) Autophagy in virus infection: a race between host immune response and viral antagonism. Immuno 2:153\u2013169","journal-title":"Immuno"},{"key":"4787_CR11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/v15040940","volume":"15","author":"L Chen","year":"2023","unstructured":"Chen L, Chen T, Li R, Xu Y, Xiong Y (2023) Recent advances in the study of the immune escape mechanism of SFTSV and its therapeutic agents. Viruses 15:940","journal-title":"Viruses"},{"key":"4787_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012725","volume":"20","author":"Z Chen","year":"2024","unstructured":"Chen Z et al (2024) N6-methyladenosine RNA modification promotes Severe Fever with Thrombocytopenia Syndrome Virus infection. PLoS Pathog 20:e1012725","journal-title":"PLoS Pathog"},{"key":"4787_CR13","doi-asserted-by":"publisher","first-page":"1624290","DOI":"10.3389\/fimmu.2025.1624290","volume":"16","author":"C Chen","year":"2025","unstructured":"Chen C et al (2025a) Latest advances and prospects in the pathogenesis, animal models, and vaccine research of severe fever with thrombocytopenia syndrome virus. Front Immunol 16:1624290","journal-title":"Front Immunol"},{"key":"4787_CR14","doi-asserted-by":"publisher","first-page":"13265","DOI":"10.2147\/JIR.S531068","volume":"18","author":"Y Chen","year":"2025","unstructured":"Chen Y et al (2025b) A focus on the mechanisms of alteration in host lymphocyte level following Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) infection. J Inflamm Res 18:13265\u201313277. https:\/\/doi.org\/10.2147\/JIR.S531068","journal-title":"J Inflamm Res"},{"key":"4787_CR15","doi-asserted-by":"publisher","first-page":"1544427","DOI":"10.3389\/fmicb.2025.1544427","volume":"16","author":"Z Chen","year":"2025","unstructured":"Chen Z, Baranwal M, Rizvanov AA, Okely M, Khaiboullina SF (2025c) Alarming implications: severe fever with thrombocytopenia syndrome and its biological vectors in the context of climate change. Front Microbiol 16:1544427","journal-title":"Front Microbiol"},{"key":"4787_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.106004","volume":"231","author":"M Cheng","year":"2024","unstructured":"Cheng M et al (2024) M\u03b2CD inhibits SFTSV entry by disrupting lipid raft structure of the host cells. Antiviral Res 231:106004. https:\/\/doi.org\/10.1016\/j.antiviral.2024.106004","journal-title":"Antiviral Res"},{"key":"4787_CR17","doi-asserted-by":"publisher","DOI":"10.1142\/S1793292020300030","volume":"15","author":"MA Chowdhury","year":"2020","unstructured":"Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A (2020) Effects of nanoparticles on viral infection\u2014a review. Nano 15:2030003","journal-title":"Nano"},{"key":"4787_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/microorganisms12020286","volume":"12","author":"ZF Dembek","year":"2024","unstructured":"Dembek ZF, Mothershead JL, Cirimotich CM, Wu A (2024) Heartland virus disease\u2014an underreported emerging infection. Microorganisms 12:286","journal-title":"Microorganisms"},{"key":"4787_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/fvl-2020-0186","volume":"16","author":"L Dou","year":"2021","unstructured":"Dou L et al (2021) shRNA targeting nonstructural protein inhibits the replication of severe fever with thrombocytopenia syndrome virus. Future Virol 16:451\u2013458. https:\/\/doi.org\/10.2217\/fvl-2020-0186","journal-title":"Future Virol"},{"key":"4787_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02799-8","volume":"37","author":"S Ekins","year":"2020","unstructured":"Ekins S, Lane TR, Madrid PB (2020) Tilorone: a broad-spectrum antiviral invented in the USA and commercialized in Russia and beyond. Pharm Res 37:71. https:\/\/doi.org\/10.1007\/s11095-020-02799-8","journal-title":"Pharm Res"},{"key":"4787_CR21","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.jtha.2023.02.006","volume":"21","author":"L Fang","year":"2023","unstructured":"Fang L et al (2023) Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation. J Thromb Haemost 21:1336\u20131351. https:\/\/doi.org\/10.1016\/j.jtha.2023.02.006","journal-title":"J Thromb Haemost"},{"key":"4787_CR22","doi-asserted-by":"crossref","unstructured":"Fares M et al (2025) SFTSV NSs protein is a novel tick antiviral RNAi response suppressor. bioRxiv:2025.2008. 2014.670292","DOI":"10.1101\/2025.08.14.670292"},{"key":"4787_CR23","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/diagnostics11091663","volume":"11","author":"M Franchini","year":"2021","unstructured":"Franchini M, Corsini F, Focosi D, Cruciani M (2021) Safety and efficacy of convalescent plasma in COVID-19: an overview of systematic reviews. Diagnostics 11:1663","journal-title":"Diagnostics"},{"key":"4787_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/v13050774","volume":"13","author":"C Gao","year":"2021","unstructured":"Gao C et al (2021) Fludarabine inhibits infection of Zika Virus, SFTS Phlebovirus, and enterovirus A71. Viruses 13:774","journal-title":"Viruses"},{"key":"4787_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00167-22","volume":"96","author":"C Gao","year":"2022","unstructured":"Gao C et al (2022) Nonstructural protein NSs activates inflammasome and pyroptosis through interaction with NLRP3 in human microglial cells infected with severe fever with thrombocytopenia syndrome bandavirus. J Virol 96:e00167-00122. https:\/\/doi.org\/10.1128\/jvi.00167-22","journal-title":"J Virol"},{"key":"4787_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106181","volume":"89","author":"H-H Ge","year":"2024","unstructured":"Ge H-H et al (2024) Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: a randomized clinical trial. J Infect 89:106181. https:\/\/doi.org\/10.1016\/j.jinf.2024.106181","journal-title":"J Infect"},{"key":"4787_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-025-02818-3","volume":"22","author":"Z Ge","year":"2025","unstructured":"Ge Z et al (2025) Analysis of the clinical efficacy of CCBs in patients with severe fever with thrombocytopenia syndrome combined with hypertension. Virol J 22:184. https:\/\/doi.org\/10.1186\/s12985-025-02818-3","journal-title":"Virol J"},{"key":"4787_CR28","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/v17121534","volume":"17","author":"M Geng","year":"2025","unstructured":"Geng M et al (2025) Identification of a novel genotype of severe fever with thrombocytopenia syndrome virus (SFTSV) in Northern Hebei Province. China Viruses 17:1534","journal-title":"China Viruses"},{"key":"4787_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03672-w","volume":"22","author":"S Guo","year":"2024","unstructured":"Guo S et al (2024) Serum lipidome reveals lipid metabolic dysregulation in severe fever with thrombocytopenia syndrome. BMC Med 22:458. https:\/\/doi.org\/10.1186\/s12916-024-03672-w","journal-title":"BMC Med"},{"key":"4787_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijid.2021.06.034","volume":"109","author":"FW Hamilton","year":"2021","unstructured":"Hamilton FW, Lee T, Arnold DT, Lilford R, Hemming K (2021) Is convalescent plasma futile in COVID-19? A bayesian re-analysis of the recovery randomized controlled trial. Int J Infect Dis 109:114\u2013117","journal-title":"Int J Infect Dis"},{"key":"4787_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01399-24","volume":"0","author":"M Han","year":"2024","unstructured":"Han M et al (2024) Efficacy of CP-COV03 (a niclosamide-based inorganic nanohybrid product) against severe fever with thrombocytopenia syndrome virus in an in vitro model. Microbiol Spectr 0:e01399-01324. https:\/\/doi.org\/10.1128\/spectrum.01399-24","journal-title":"Microbiol Spectr"},{"key":"4787_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00796-23","volume":"97","author":"X He","year":"2023","unstructured":"He X et al (2023) Identification of tanshinone I as cap-dependent endonuclease inhibitor with broad-spectrum antiviral effect. J Virol 97:e00796-00723. https:\/\/doi.org\/10.1128\/jvi.00796-23","journal-title":"J Virol"},{"key":"4787_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13121186","volume":"13","author":"Q He","year":"2025","unstructured":"He Q et al (2025) The DNA vaccines for the Gn and Gc heterologous polymer of severe fever with thrombocytopenia syndrome virus induce potent immunogenicity in mice. Vaccines 13:1186","journal-title":"Vaccines"},{"key":"4787_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121403","volume":"12","author":"P Hicks","year":"2024","unstructured":"Hicks P et al (2024) Safety, immunogenicity, and efficacy of a recombinant vesicular stomatitis virus vectored vaccine against severe fever with thrombocytopenia syndrome virus and heartland bandavirus. Vaccines 12:1403","journal-title":"Vaccines"},{"key":"4787_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1650652","volume":"15","author":"S-T Hong","year":"2025","unstructured":"Hong S-T, Ganbold T, Acharya S, Sheet S (2025) Advancements in vaccine development and therapeutic approaches for severe fever with Thrombocytopenia Syndrome. Front Cell Infect Microbiol 15:1650652","journal-title":"Front Cell Infect Microbiol"},{"key":"4787_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.71328","volume":"8","author":"H Hou","year":"2025","unstructured":"Hou H, Yuan X, Chen R, Xiong Z, Wu S, Wang F (2025) Recent advances in humoral immunity dysregulation in severe fever with Thrombocytopenia Syndrome Virus (SFTSV) infection: a systematic review. Health Sci Rep 8:e71328. https:\/\/doi.org\/10.1002\/hsr2.71328","journal-title":"Health Sci Rep"},{"key":"4787_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.790714","volume":"12","author":"T Hu","year":"2021","unstructured":"Hu T, Pan M, Yin Y, Wang C, Cui Y, Wang Q (2021) The regulatory network of cyclic GMP-AMP synthase-stimulator of interferon genes pathway in viral evasion. Front Microbiol 12:790714. https:\/\/doi.org\/10.3389\/fmicb.2021.790714","journal-title":"Front Microbiol"},{"key":"4787_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1046176","author":"H Huang","year":"2022","unstructured":"Huang H et al (2022) Cyclophilin A causes severe fever with thrombocytopenia syndrome virus-induced cytokine storm by regulating mitogen-activated protein kinase pathway. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.1046176","journal-title":"Front Microbiol"},{"key":"4787_CR39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D (2014) From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 5:514","journal-title":"Front Immunol"},{"key":"4787_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105818","volume":"222","author":"R Izmailyan","year":"2024","unstructured":"Izmailyan R et al (2024) Discovery of new antiviral agents through artificial intelligence: in vitro and in vivo results. Antiviral Res 222:105818","journal-title":"Antiviral Res"},{"key":"4787_CR41","doi-asserted-by":"publisher","first-page":"e29099","DOI":"10.1002\/jmv.29099","volume":"95","author":"K Jeon","year":"2023","unstructured":"Jeon K et al (2023) A natural variation in the RNA polymerase of severe fever with thrombocytopenia syndrome virus enhances viral replication and in vivo virulence. J Med Virol 95:e29099","journal-title":"J Med Virol"},{"key":"4787_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012999","volume":"19","author":"D-E Jeong","year":"2025","unstructured":"Jeong D-E, Yoon J, Kim B, Kang J-G (2025) The immunogenicity and protection efficacy evaluation of mRNA vaccine candidate for severe fever with thrombocytopenia syndrome in mice. PLoS Negl Trop Dis 19:e0012999","journal-title":"PLoS Negl Trop Dis"},{"key":"4787_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s44321-024-00026-0","volume":"16","author":"M Ji","year":"2024","unstructured":"Ji M et al (2024) Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO Mol Med 16:575\u2013595. https:\/\/doi.org\/10.1038\/s44321-024-00026-0","journal-title":"EMBO Mol Med"},{"key":"4787_CR44","doi-asserted-by":"publisher","first-page":"105916","DOI":"10.1016\/j.antiviral.2024.105916","volume":"227","author":"N Jiang","year":"2024","unstructured":"Jiang N et al (2024a) 6-Thioguanine inhibits severe fever with thrombocytopenia syndrome virus through suppression of EGR1. Antiviral Res 227:105916. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105916","journal-title":"Antiviral Res"},{"key":"4787_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03796-23","volume":"12","author":"Z-z Jiang","year":"2024","unstructured":"Jiang Z-z et al (2024b) SFTSV nucleoprotein mediates DNA sensor cGAS degradation to suppress cGAS-dependent antiviral responses. Microbiol Spectr 12:e03796-03723. https:\/\/doi.org\/10.1128\/spectrum.03796-23","journal-title":"Microbiol Spectr"},{"key":"4787_CR46","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/infdis\/jiu564","volume":"211","author":"C Jin","year":"2015","unstructured":"Jin C et al (2015) SFTS virus infection in nonhuman primates. J Infect Dis 211:915\u2013925","journal-title":"J Infect Dis"},{"key":"4787_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s43141-020-00095-x","volume":"18","author":"A Joshi","year":"2020","unstructured":"Joshi A, Sunil Krishnan G, Kaushik V (2020) Molecular docking and simulation investigation: effect of beta-sesquiphellandrene with ionic integration on SARS-CoV2 and SFTS viruses. J Genet Eng Biotechnol 18:78. https:\/\/doi.org\/10.1186\/s43141-020-00095-x","journal-title":"J Genet Eng Biotechnol"},{"key":"4787_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009128","volume":"15","author":"SI Jung","year":"2021","unstructured":"Jung SI et al (2021) Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: a multicenter clinical cohort study. PLoS Negl Trop Dis 15:e0009128. https:\/\/doi.org\/10.1371\/journal.pntd.0009128","journal-title":"PLoS Negl Trop Dis"},{"key":"4787_CR49","doi-asserted-by":"publisher","first-page":"e0007813","DOI":"10.1371\/journal.pntd.0007813","volume":"14","author":"J-G Kang","year":"2020","unstructured":"Kang J-G et al (2020) Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice. PLoS Negl Trop Dis 14:e0007813","journal-title":"PLoS Negl Trop Dis"},{"key":"4787_CR50","doi-asserted-by":"crossref","unstructured":"Karim M, Lo C-W, Einav S (2023) Preparing for the next viral threat with broad-spectrum antivirals. J Clin Investig 133","DOI":"10.1172\/JCI170236"},{"key":"4787_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/v13050785","volume":"13","author":"T Kawaguchi","year":"2021","unstructured":"Kawaguchi T et al (2021) Corticosteroids may have negative effects on the management of patients with severe fever with thrombocytopenia syndrome: a case\u2013control study. Viruses 13:785","journal-title":"Viruses"},{"key":"4787_CR52","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/v13050876","volume":"13","author":"J Khalil","year":"2021","unstructured":"Khalil J, Kato H, Fujita T (2021) The role of non-structural protein NSs in the pathogenesis of severe fever with thrombocytopenia syndrome. Viruses 13:876","journal-title":"Viruses"},{"key":"4787_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01868-23","volume":"14","author":"D Kim","year":"2023","unstructured":"Kim D et al (2023a) Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets. MBio 14:e01868-01823. https:\/\/doi.org\/10.1128\/mbio.01868-23","journal-title":"MBio"},{"key":"4787_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29203","volume":"95","author":"D Kim","year":"2023","unstructured":"Kim D et al (2023b) SFTSV Gn-head mRNA vaccine confers efficient protection against lethal viral challenge. J Med Virol 95:e29203. https:\/\/doi.org\/10.1002\/jmv.29203","journal-title":"J Med Virol"},{"key":"4787_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41541-023-00771-2","volume":"8","author":"J-Y Kim","year":"2023","unstructured":"Kim J-Y et al (2023c) mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice. NPJ Vaccines 8:167","journal-title":"NPJ Vaccines"},{"key":"4787_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00771-2","volume":"8","author":"J-Y Kim","year":"2023","unstructured":"Kim J-Y et al (2023d) mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice. NPJ Vaccines 8:167. https:\/\/doi.org\/10.1038\/s41541-023-00771-2","journal-title":"NPJ Vaccines"},{"key":"4787_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/v16010128","volume":"16","author":"D Kim","year":"2024","unstructured":"Kim D, Lai C-J, Cha I, Jung JU (2024a) Current progress of severe fever with thrombocytopenia syndrome virus (SFTSV) vaccine development. Viruses 16:128","journal-title":"Viruses"},{"key":"4787_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1348276","author":"S Kim","year":"2024","unstructured":"Kim S, Jeon K, Choi H, Jeong D-E, Kang J-G, Cho N-H (2024b) Comparative analysis of the efficacy of vaccines using structural protein subunits of the severe fever with thrombocytopenia syndrome virus. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1348276","journal-title":"Front Microbiol"},{"key":"4787_CR59","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jiac.2023.01.022","volume":"29","author":"S Kutsuna","year":"2023","unstructured":"Kutsuna S, Ohbe H, Matsui H, Yasunaga H (2023) Steroid pulse therapy for severe fever with thrombocytopenia syndrome patients May not improve prognosis: retrospective analysis with overlap weighting using a National inpatient database. J Infect Chemother 29:490\u2013494. https:\/\/doi.org\/10.1016\/j.jiac.2023.01.022","journal-title":"J Infect Chemother"},{"key":"4787_CR60","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1038\/s41467-019-11815-4","volume":"10","author":"J-E Kwak","year":"2019","unstructured":"Kwak J-E et al (2019) Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets. Nat Commun 10:3836","journal-title":"Nat Commun"},{"key":"4787_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae508","author":"J-S Kwon","year":"2024","unstructured":"Kwon J-S et al (2024) Effect of Severe Fever With Thrombocytopenia Syndrome Virus Genotype on Disease Severity, Viral Load, and Cytokines in South Korea. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofae508","journal-title":"Open Forum Infect Dis"},{"key":"4787_CR62","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ttbdis.2017.04.008","volume":"8","author":"S-H Lee","year":"2017","unstructured":"Lee S-H et al (2017) Molecular detection and phylogenetic analysis of severe fever with thrombocytopenia syndrome virus in shelter dogs and cats in the Republic of Korea. Ticks Tick-borne Dis 8:626\u2013630","journal-title":"Ticks Tick-borne Dis"},{"key":"4787_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71438-8","volume":"14","author":"JM Lee","year":"2024","unstructured":"Lee JM et al (2024) Acute kidney injury as a prognostic marker in severe fever with thrombocytopenia syndrome. Sci Rep 14:20651. https:\/\/doi.org\/10.1038\/s41598-024-71438-8","journal-title":"Sci Rep"},{"key":"4787_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113735","volume":"382","author":"S-Y Lee","year":"2025","unstructured":"Lee S-Y et al (2025) The therapeutic potential of mRNA-encoded SFTSV human monoclonal antibody encapsulated lipid nanoparticle in vivo. J Control Release 382:113735","journal-title":"J Control Release"},{"key":"4787_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.micinf.2014.12.002","volume":"17","author":"X-Y Lei","year":"2015","unstructured":"Lei X-Y, Liu M-M, Yu X-J (2015) Severe fever with thrombocytopenia syndrome and its pathogen SFTSV. Microbes Infect 17:149\u2013154","journal-title":"Microbes Infect"},{"key":"4787_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06853-1","volume":"7","author":"Z Li","year":"2017","unstructured":"Li Z et al (2017) Increased prevalence of severe fever with thrombocytopenia syndrome in Eastern China clustered with multiple genotypes and reasserted virus during 2010\u20132015. Sci Rep 7:6503","journal-title":"Sci Rep"},{"key":"4787_CR67","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","volume":"18","author":"H Li","year":"2018","unstructured":"Li H et al (2018a) Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011\u201317: a prospective observational study. Lancet Infect Dis 18:1127\u20131137","journal-title":"Lancet Infect Dis"},{"key":"4787_CR68","doi-asserted-by":"publisher","first-page":"eaat4162","DOI":"10.1126\/scitranslmed.aat4162","volume":"10","author":"X-K Li","year":"2018","unstructured":"Li X-K et al (2018b) Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Sci Transl Med 10:eaat4162","journal-title":"Sci Transl Med"},{"key":"4787_CR69","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","volume":"29","author":"H Li","year":"2019","unstructured":"Li H et al (2019) Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res 29:739\u2013753. https:\/\/doi.org\/10.1038\/s41422-019-0214-z","journal-title":"Cell Res"},{"key":"4787_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00541-3","volume":"6","author":"H Li","year":"2021","unstructured":"Li H et al (2021a) Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome. Signal Transduct Target Ther 6:145. https:\/\/doi.org\/10.1038\/s41392-021-00541-3","journal-title":"Signal Transduct Target Ther"},{"key":"4787_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.735223","author":"S Li","year":"2021","unstructured":"Li S et al (2021b) Screening of a small molecule compound library identifies toosendanin as an inhibitor against bunyavirus and SARS-CoV-2. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.735223","journal-title":"Front Pharmacol"},{"key":"4787_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.imj.2021.10.001","volume":"1","author":"J-C Li","year":"2022","unstructured":"Li J-C, Zhao J, Li H, Fang L-Q, Liu W (2022) Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndrome. Infect Med 1:40\u201349","journal-title":"Infect Med"},{"key":"4787_CR73","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1080\/15548627.2024.2356505","volume":"20","author":"Z-M Li","year":"2024","unstructured":"Li Z-M et al (2024) Bunyavirus SFTSV NSs utilizes autophagy to escape the antiviral innate immune response. Autophagy 20:2133\u20132145. https:\/\/doi.org\/10.1080\/15548627.2024.2356505","journal-title":"Autophagy"},{"key":"4787_CR74","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/22221751.2019.1710436","volume":"9","author":"T-L Lin","year":"2020","unstructured":"Lin T-L et al (2020) The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan. Emerg Microbes Infect 9:148\u2013151","journal-title":"Emerg Microbes Infect"},{"key":"4787_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/vim.2014.0100","volume":"28","author":"R Liu","year":"2015","unstructured":"Liu R et al (2015) Immunization with recombinant SFTSV\/NSs protein does not promote virus clearance in SFTSV-infected C57BL\/6J mice. Viral Immunol 28:113\u2013122","journal-title":"Viral Immunol"},{"key":"4787_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2024.08.002","author":"J Liu","year":"2024","unstructured":"Liu J, Chai Z, Ma Q, Li D, Yuan G (2024a) The immun function of dendritic cells in SFTS patients. J Infect Chemother. https:\/\/doi.org\/10.1016\/j.jiac.2024.08.002","journal-title":"J Infect Chemother"},{"key":"4787_CR77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12985-024-02564-y","volume":"21","author":"R Liu","year":"2024","unstructured":"Liu R et al (2024b) Pathogen isolation and traceability analysis of a fatal case of severe fever with thrombocytopenia syndrome virus (SFTSV) infectious encephalitis in China. Virol J 21:300","journal-title":"Virol J"},{"key":"4787_CR78","doi-asserted-by":"publisher","first-page":"e00786","DOI":"10.1128\/jvi.00786-24","volume":"98","author":"Z Liu","year":"2024","unstructured":"Liu Z et al (2024c) The differences in cytokine signatures between severe fever with thrombocytopenia syndrome (SFTS) and hemorrhagic fever with renal syndrome (HFRS). J Virol 98:e00786\u2013e00724. https:\/\/doi.org\/10.1128\/jvi.00786-24","journal-title":"J Virol"},{"key":"4787_CR79","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00769-24","author":"J Lu","year":"2024","unstructured":"Lu J et al (2024) A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses. J Virol. https:\/\/doi.org\/10.1128\/jvi.00769-24","journal-title":"J Virol"},{"key":"4787_CR80","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/08828245251381140","volume":"38","author":"W Lu","year":"2025","unstructured":"Lu W et al (2025) Antibody development strategies for SFTSV: from hybridoma to emerging technologies. Viral Immunol 38:269\u2013279. https:\/\/doi.org\/10.1177\/08828245251381140","journal-title":"Viral Immunol"},{"key":"4787_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2024.08.007","author":"C Luo","year":"2024","unstructured":"Luo C et al (2024) Antiviral activity of vitamin D derivatives against severe fever with thrombocytopenia syndrome virus in vitro and in vivo. Virol Sin. https:\/\/doi.org\/10.1016\/j.virs.2024.08.007","journal-title":"Virol Sin"},{"key":"4787_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/v17081095","volume":"17","author":"TB Manzoni","year":"2025","unstructured":"Manzoni TB et al (2025) Homologous and heterologous vaccination regimens with mRNA and rVSV platforms induce potent immune responses against SFTSV glycoprotein. Viruses 17:1095","journal-title":"Viruses"},{"key":"4787_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040125","volume":"7","author":"CA Mendoza","year":"2019","unstructured":"Mendoza CA, Ebihara H, Yamaoka S (2019) Immune modulation and immune-mediated pathogenesis of emerging tickborne Banyangviruses. Vaccines 7:125","journal-title":"Vaccines"},{"key":"4787_CR84","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-981-15-2651-0_15","volume-title":"Animal-Origin Viral Zoonoses","author":"AAP Milton","year":"2020","unstructured":"Milton AAP, Priya GB, Ghatak S, Das S (2020) Viral zoonoses: wildlife perspectives. Animal-Origin Viral Zoonoses. Springer, pp 339\u2013378"},{"key":"4787_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00298","volume":"8","author":"L Mlera","year":"2018","unstructured":"Mlera L, Bloom ME (2018) The role of mammalian reservoir hosts in tick-borne flavivirus biology. Front Cell Infect Microbiol 8:298","journal-title":"Front Cell Infect Microbiol"},{"key":"4787_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1348836","volume":"15","author":"Y Niu","year":"2024","unstructured":"Niu Y et al (2024) Antiviral immunity of severe fever with thrombocytopenia syndrome: current understanding and implications for clinical treatment. Front Immunol 15:1348836","journal-title":"Front Immunol"},{"key":"4787_CR87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jiac.2020.08.005","volume":"27","author":"M Ogawa","year":"2021","unstructured":"Ogawa M, Shimojima M, Saijo M, Fukasawa M (2021a) Several catechins and flavonols from green tea inhibit severe fever with thrombocytopenia syndrome virus infection in vitro. J Infect Chemother 27:32\u201339. https:\/\/doi.org\/10.1016\/j.jiac.2020.08.005","journal-title":"J Infect Chemother"},{"key":"4787_CR88","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jiac.2020.10.015","volume":"27","author":"M Ogawa","year":"2021","unstructured":"Ogawa M et al (2021b) Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus. J Infect Chemother 27:397\u2013400. https:\/\/doi.org\/10.1016\/j.jiac.2020.10.015","journal-title":"J Infect Chemother"},{"key":"4787_CR89","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.cell.2014.04.016","volume":"157","author":"Y Okabe","year":"2014","unstructured":"Okabe Y, Medzhitov R (2014) Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157:832\u2013844","journal-title":"Cell"},{"key":"4787_CR90","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/v16060874","volume":"16","author":"H Osako","year":"2024","unstructured":"Osako H et al (2024) Clinical factors associated with SFTS diagnosis and severity in cats. Viruses 16:874","journal-title":"Viruses"},{"key":"4787_CR91","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2169\/internalmedicine.2504-23","volume":"63","author":"Y Otsuka","year":"2024","unstructured":"Otsuka Y, Tanizaki R, Nomura Y (2024) Leukocytoclastic vasculitis secondary to severe fever with thrombocytopenia syndrome. Intern Med 63:1479\u20131483. https:\/\/doi.org\/10.2169\/internalmedicine.2504-23","journal-title":"Intern Med"},{"key":"4787_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veae054","author":"D Park","year":"2024","unstructured":"Park D et al (2024) Deciphering the evolutionary landscape of severe fever with thrombocytopenia syndrome virus across East Asia. Virus Evol. https:\/\/doi.org\/10.1093\/ve\/veae054","journal-title":"Virus Evol"},{"key":"4787_CR93","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.3390\/ijms22179198","volume":"22","author":"AI Pogue","year":"2021","unstructured":"Pogue AI, Lukiw WJ (2021) MicroRNA-146a-5p, neurotropic viral infection and prion disease (PrD). Int J Mol Sci 22:9198","journal-title":"Int J Mol Sci"},{"key":"4787_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00993-y","volume":"9","author":"H Qian","year":"2024","unstructured":"Qian H et al (2024) Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice. NPJ Vaccines 9:194. https:\/\/doi.org\/10.1038\/s41541-024-00993-y","journal-title":"NPJ Vaccines"},{"key":"4787_CR95","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-981-96-3456-9_9","volume-title":"RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis","author":"V Ranga","year":"2025","unstructured":"Ranga V (2025) Clinical Trials on RNA-Based Therapeutics for the Treatment of Infectious Diseases and Other Pathologies. RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis. Springer, pp 207\u2013229"},{"key":"4787_CR96","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coviro.2018.03.005","volume":"29","author":"LM Reece","year":"2018","unstructured":"Reece LM, Beasley DW, Milligan GN, Sarathy VV, Barrett AD (2018) Current status of severe fever with thrombocytopenia syndrome vaccine development. Curr Opin Virol 29:72\u201378","journal-title":"Curr Opin Virol"},{"key":"4787_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51108-z","volume":"15","author":"X Ren","year":"2024","unstructured":"Ren X et al (2024) A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection. Nat Commun 15:7009. https:\/\/doi.org\/10.1038\/s41467-024-51108-z","journal-title":"Nat Commun"},{"key":"4787_CR98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-981-13-9562-8_13","volume-title":"Severe fever with thrombocytopenia syndrome","author":"M Saijo","year":"2019","unstructured":"Saijo M (2019) Circulation of severe fever with thrombocytopenia syndrome virus (SFTSV) in nature: transmission of SFTSV between mammals and ticks. Severe fever with thrombocytopenia syndrome. Springer, pp 151\u2013172"},{"key":"4787_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s42522-024-00112-w","volume":"6","author":"C Sansilapin","year":"2024","unstructured":"Sansilapin C et al (2024) Severe fever with thrombocytopenia syndrome (SFTS) in Thailand: using a one health approach to respond to novel zoonosis and its implications in clinical practice. One Health Outlook 6:18. https:\/\/doi.org\/10.1186\/s42522-024-00112-w","journal-title":"One Health Outlook"},{"key":"4787_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s13237-024-00495-1","author":"S Sengupta","year":"2024","unstructured":"Sengupta S, Mohanty S, Rababi D, Nag A (2024) A comprehensive molecular docking-based study to identify potential drug-candidates against the novel and emerging severe fever with thrombocytopenia syndrome virus (SFTSV) by targeting the nucleoprotein. Nucleus. https:\/\/doi.org\/10.1007\/s13237-024-00495-1","journal-title":"Nucleus"},{"key":"4787_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/v13071213","author":"JW Seo","year":"2021","unstructured":"Seo JW, Kim D, Yun N, Kim DM (2021) Clinical update of severe fever with thrombocytopenia syndrome. Viruses. https:\/\/doi.org\/10.3390\/v13071213","journal-title":"Viruses"},{"key":"4787_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02558-z","volume":"20","author":"S Shen","year":"2022","unstructured":"Shen S et al (2022) Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases. BMC Med 20:359. https:\/\/doi.org\/10.1186\/s12916-022-02558-z","journal-title":"BMC Med"},{"key":"4787_CR103","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.meegid.2016.11.015","volume":"47","author":"J Shi","year":"2017","unstructured":"Shi J et al (2017) Migration, recombination, and reassortment are involved in the evolution of severe fever with thrombocytopenia syndrome bunyavirus. Infect Genet Evol 47:109\u2013117","journal-title":"Infect Genet Evol"},{"key":"4787_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virol.2015.03.010","volume":"482","author":"S Shimada","year":"2015","unstructured":"Shimada S, Posadas-Herrera G, Aoki K, Morita K, Hayasaka D (2015) Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection. Virology 482:19\u201327. https:\/\/doi.org\/10.1016\/j.virol.2015.03.010","journal-title":"Virology"},{"key":"4787_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012348","volume":"20","author":"M Shimojima","year":"2024","unstructured":"Shimojima M et al (2024) N-glycosylation of viral glycoprotein is a novel determinant for the tropism and virulence of highly pathogenic tick-borne bunyaviruses. PLoS Pathog 20:e1012348. https:\/\/doi.org\/10.1371\/journal.ppat.1012348","journal-title":"PLoS Pathog"},{"key":"4787_CR106","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad418","volume":"10","author":"H Shuto","year":"2023","unstructured":"Shuto H et al (2023) Corticosteroid therapy for patients with severe fever with thrombocytopenia syndrome: a nationwide propensity score\u2013matched study in Japan. Open Forum Infect Dis 10:ofad418. https:\/\/doi.org\/10.1093\/ofid\/ofad418","journal-title":"Open Forum Infect Dis"},{"key":"4787_CR107","first-page":"105","volume":"4","author":"L Singh","year":"2017","unstructured":"Singh L, Kruger HG, Maguire GE, Govender T, Parboosing R (2017) The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis 4:105\u2013131","journal-title":"Ther Adv Infect Dis"},{"key":"4787_CR108","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s15010-019-01364-9","volume":"48","author":"R Song","year":"2020","unstructured":"Song R, Chen Z, Li W (2020) Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705). Infection 48:295\u2013298. https:\/\/doi.org\/10.1007\/s15010-019-01364-9","journal-title":"Infection"},{"key":"4787_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22131","volume":"39","author":"X Song","year":"2024","unstructured":"Song X, Xu X, Ren X, Ruan X, Bo J (2024) Therapeutic plasma exchange combined with ribavirin to rescue critical SFTS patients. J Clin Apheresis 39:e22131","journal-title":"J Clin Apheresis"},{"key":"4787_CR110","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/v8070202","volume":"8","author":"M Spiegel","year":"2016","unstructured":"Spiegel M, Plegge T, P\u00f6hlmann S (2016) The role of phlebovirus glycoproteins in viral entry, assembly and release. Viruses 8:202","journal-title":"Viruses"},{"key":"4787_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01269-9","volume":"10","author":"A Stamper","year":"2025","unstructured":"Stamper A et al (2025) A replicating RNA vaccine protects against severe fever with thrombocytopenia syndrome virus infection in mice. NPJ Vaccines 10:219","journal-title":"NPJ Vaccines"},{"key":"4787_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009103","volume":"15","author":"K Suemori","year":"2021","unstructured":"Suemori K et al (2021) A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome. PLoS Negl Trop Dis 15:e0009103","journal-title":"PLoS Negl Trop Dis"},{"key":"4787_CR113","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2309990","volume":"13","author":"Y Sun","year":"2024","unstructured":"Sun Y et al (2024) The first reported cases of severe fever with thrombocytopenia syndrome virus from domestic sick camel to humans in China. Emerg Microbes Infect 13:2309990. https:\/\/doi.org\/10.1080\/22221751.2024.2309990","journal-title":"Emerg Microbes Infect"},{"key":"4787_CR114","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/ijmm.2025.5610","volume":"56","author":"H Sun","year":"2025","unstructured":"Sun H et al (2025) Current status of severe fever with thrombocytopenia syndrome in China. Int J Mol Med 56:169","journal-title":"Int J Mol Med"},{"key":"4787_CR115","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fmicb.2020.00150","volume":"11","author":"M Takayama-Ito","year":"2020","unstructured":"Takayama-Ito M, Saijo M (2020) Antiviral drugs against severe fever with thrombocytopenia syndrome virus infection. Front Microbiol 11:150","journal-title":"Front Microbiol"},{"key":"4787_CR116","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00061-15","volume":"1","author":"H Tani","year":"2016","unstructured":"Tani H et al (2016) Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus. mSphere 1:10.1128\/msphere.00061\u2009\u2212\u200900015. https:\/\/doi.org\/10.1128\/msphere.00061-15","journal-title":"mSphere"},{"key":"4787_CR117","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3201\/eid2505.181463","volume":"25","author":"XC Tran","year":"2019","unstructured":"Tran XC et al (2019) Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg Infect Dis 25:1029","journal-title":"Emerg Infect Dis"},{"key":"4787_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fviro.2022.1064265","author":"S Urata","year":"2023","unstructured":"Urata S et al (2023a) Identification of surfactin as an anti-severe fever with thrombocytopenia syndrome virus multi-target compound extracted from the culture broth of marine microbes. Front Virol 2. https:\/\/doi.org\/10.3389\/fviro.2022.1064265","journal-title":"Front Virol 2"},{"key":"4787_CR119","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00015-23","volume":"97","author":"S Urata","year":"2023","unstructured":"Urata S, Yoshikawa R, Yasuda J (2023b) Calcium influx regulates the replication of several negative-strand RNA viruses including severe fever with thrombocytopenia syndrome virus. J Virol 97:e00015-00023. https:\/\/doi.org\/10.1128\/jvi.00015-23","journal-title":"J Virol"},{"key":"4787_CR120","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.tim.2021.02.006","volume":"29","author":"C Viret","year":"2021","unstructured":"Viret C, Duclaux-Loras R, Nancey S, Rozi\u00e8res A, Faure M (2021) Selective autophagy receptors in antiviral defense. Trends Microbiol 29:798\u2013810","journal-title":"Trends Microbiol"},{"key":"4787_CR121","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1039\/D1RA06702H","volume":"12","author":"R Vivek-Ananth","year":"2022","unstructured":"Vivek-Ananth R, Sahoo AK, Srivastava A, Samal A (2022) Virtual screening of phytochemicals from Indian medicinal plants against the endonuclease domain of SFTS virus L polymerase. RSC Adv 12:6234\u20136247","journal-title":"RSC Adv"},{"key":"4787_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1419015","author":"H Wang","year":"2024","unstructured":"Wang H (2024) The use of glucocorticoid in severe fever with thrombocytopenia syndrome: a retrospective cohort study. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2024.1419015","journal-title":"Front Cell Infect Microbiol"},{"key":"4787_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.725642","author":"L Wang","year":"2022","unstructured":"Wang L, Xu Y, Zhang S, Bibi A, Xu Y, Li T (2022) The AST\/ALT ratio (de ritis ratio) represents an unfavorable prognosis in patients in early-stage SFTS: an observational cohort study. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2022.725642","journal-title":"Front Cell Infect Microbiol"},{"key":"4787_CR124","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijid.2023.03.015","volume":"130","author":"G Wang","year":"2023","unstructured":"Wang G et al (2023) Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: a retrospective cohort study. Int J Infect Dis 130:153\u2013160. https:\/\/doi.org\/10.1016\/j.ijid.2023.03.015","journal-title":"Int J Infect Dis"},{"key":"4787_CR125","doi-asserted-by":"publisher","first-page":"7627","DOI":"10.2147\/JIR.S478520","volume":"17","author":"G Wang","year":"2024","unstructured":"Wang G et al (2024) Impact of glucocorticoid therapy on 28-day mortality in patients having severe fever with thrombocytopenia syndrome in an intensive care unit: a retrospective analysis. J Inflamm Res 17:7627\u20137637. https:\/\/doi.org\/10.2147\/JIR.S478520","journal-title":"J Inflamm Res"},{"key":"4787_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03421-z","volume":"22","author":"S Wen","year":"2024","unstructured":"Wen S et al (2024) Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial. BMC Med 22:204. https:\/\/doi.org\/10.1186\/s12916-024-03421-z","journal-title":"BMC Med"},{"key":"4787_CR127","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev-virology-092818-015811","volume":"6","author":"JB Withers","year":"2019","unstructured":"Withers JB et al (2019) Idiosyncrasies of viral noncoding RNAs provide insights into host cell biology. Annu Rev Virol 6:297\u2013317. https:\/\/doi.org\/10.1146\/annurev-virology-092818-015811","journal-title":"Annu Rev Virol"},{"key":"4787_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102685","author":"D Woo","year":"2025","unstructured":"Woo D, Michelow IC, Choi Y, Lee H, Park S (2025) Transmission of severe fever with thrombocytopenia syndrome (SFTS) to humans: a systematic review of individual participant data and meta-analysis. J Infect Public Health. https:\/\/doi.org\/10.1016\/j.jiph.2025.102685","journal-title":"J Infect Public Health"},{"key":"4787_CR129","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12250-020-00289-0","volume":"36","author":"X Wu","year":"2021","unstructured":"Wu X et al (2021) Novel SFTSV phylogeny reveals new reassortment events and migration routes. Virol Sin 36:300\u2013310","journal-title":"Virol Sin"},{"key":"4787_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012216","volume":"18","author":"X Wu","year":"2024","unstructured":"Wu X et al (2024) Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses. PLoS Negl Trop Dis 18:e0012216. https:\/\/doi.org\/10.1371\/journal.pntd.0012216","journal-title":"PLoS Negl Trop Dis"},{"key":"4787_CR131","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12879-021-06627-1","volume":"21","author":"Y Xu","year":"2021","unstructured":"Xu Y, Shao M, Liu N, Dong D, Tang J, Gu Q (2021) Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis\/encephalopathy: a retrospective study. BMC Infect Dis 21:904. https:\/\/doi.org\/10.1186\/s12879-021-06627-1","journal-title":"BMC Infect Dis"},{"key":"4787_CR132","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/JIR.S444398","volume":"17","author":"D-L Xu","year":"2024","unstructured":"Xu D-L et al (2024a) Changes in cytokine levels in patients with severe fever with thrombocytopenia syndrome virus. J Inflamm Res 17:211\u2013222. https:\/\/doi.org\/10.2147\/JIR.S444398","journal-title":"J Inflamm Res"},{"key":"4787_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104944","author":"H Xu","year":"2024","unstructured":"Xu H et al (2024b) A nanoluciferase SFTSV for rapid screening antivirals and\u00a0real-time visualization of virus infection in mice. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104944","journal-title":"EBioMedicine"},{"key":"4787_CR134","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2169\/internalmedicine.9052-21","volume":"62","author":"N Yamauchi","year":"2023","unstructured":"Yamauchi N et al (2023) Successful recovery from severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis with standard treatment and a calcium channel blocker of nicardipine hydrochloride. Intern Med 62:1365\u20131369. https:\/\/doi.org\/10.2169\/internalmedicine.9052-21","journal-title":"Intern Med"},{"key":"4787_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2021.198594","volume":"306","author":"J-m Yan","year":"2021","unstructured":"Yan J-m, Zhang W-k, Li F, Zhou C-m, Yu X-j (2021) Integrated transcriptome profiling in THP-1 macrophages infected with bunyavirus SFTSV. Virus Res 306:198594. https:\/\/doi.org\/10.1016\/j.virusres.2021.198594","journal-title":"Virus Res"},{"key":"4787_CR136","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1080\/15548627.2021.1994296","volume":"18","author":"JM Yan","year":"2022","unstructured":"Yan JM, Zhang WK, Yan LN, Jiao YJ, Zhou CM, Yu XJ (2022) Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress. Autophagy 18:1599\u20131612. https:\/\/doi.org\/10.1080\/15548627.2021.1994296","journal-title":"Autophagy"},{"key":"4787_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/v16081332","volume":"16","author":"X Yan","year":"2024","unstructured":"Yan X et al (2024) Antiviral activity of selective estrogen receptor modulators against severe fever with thrombocytopenia syndrome virus in vitro and in vivo. Viruses 16:1332","journal-title":"Viruses"},{"key":"4787_CR138","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.virs.2022.01.014","volume":"37","author":"J Yang","year":"2022","unstructured":"Yang J et al (2022) Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus. Virol Sin 37:145\u2013148. https:\/\/doi.org\/10.1016\/j.virs.2022.01.014","journal-title":"Virol Sin"},{"key":"4787_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012550","volume":"20","author":"P Yang","year":"2024","unstructured":"Yang P et al (2024) Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV. PLoS Pathog 20:e1012550. https:\/\/doi.org\/10.1371\/journal.ppat.1012550","journal-title":"PLoS Pathog"},{"key":"4787_CR140","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3343\/alm.2020.40.4.317","volume":"40","author":"IY Yoo","year":"2020","unstructured":"Yoo IY, Kim J-Y, Yoon YK, Huh HJ, Lee NY (2020) Comparison between the SFTS-QS kit and the powerchek SFTSV real-time PCR kit for the detection of severe fever with thrombocytopenia syndrome virus. Alm 40:317\u2013320. https:\/\/doi.org\/10.3343\/alm.2020.40.4.317","journal-title":"Alm"},{"key":"4787_CR141","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/v13040627","volume":"13","author":"T Yoshikawa","year":"2021","unstructured":"Yoshikawa T (2021) Vaccine development for severe fever with thrombocytopenia syndrome. Viruses 13:627","journal-title":"Viruses"},{"key":"4787_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1622394","volume":"16","author":"Y Yu","year":"2025","unstructured":"Yu Y, Li J, Liu Q, Zhai R, Dai Y, Lei S (2025) Advances in research on severe fever with thrombocytopenia syndrome virus. Front Microbiol 16:1622394","journal-title":"Front Microbiol"},{"key":"4787_CR143","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12250-016-3858-6","volume":"32","author":"F Yuan","year":"2017","unstructured":"Yuan F, Zheng A (2017) Entry of severe fever with thrombocytopenia syndrome virus. Virol Sin 32:44\u201350","journal-title":"Virol Sin"},{"key":"4787_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103591","author":"Y Yuan","year":"2021","unstructured":"Yuan Y et al (2021) Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103591","journal-title":"EBioMedicine"},{"key":"4787_CR145","doi-asserted-by":"publisher","DOI":"10.3201\/eid2008.131857","volume":"20","author":"S-M Yun","year":"2014","unstructured":"Yun S-M et al (2014) Severe fever with thrombocytopenia syndrome virus in ticks collected from humans, South Korea, 2013. Emerg Infect Dis 20:1358","journal-title":"Emerg Infect Dis"},{"key":"4787_CR146","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129531","volume":"5","author":"S-M Yun","year":"2020","unstructured":"Yun S-M et al (2020) Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea. JCI Insight 5:e129531","journal-title":"JCI Insight"},{"key":"4787_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01095","author":"L Zhang","year":"2019","unstructured":"Zhang L et al (2019a) Severe fever with thrombocytopenia syndrome virus-induced macrophage differentiation is regulated by miR-146. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01095","journal-title":"Front Immunol"},{"key":"4787_CR148","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3389\/fimmu.2019.01095","volume":"10","author":"L Zhang","year":"2019","unstructured":"Zhang L et al (2019b) Severe fever with thrombocytopenia syndrome virus-induced macrophage differentiation is regulated by miR-146. Front Immunol 10:1095","journal-title":"Front Immunol"},{"key":"4787_CR149","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3201\/eid2802.211532","volume":"28","author":"X Zhang","year":"2022","unstructured":"Zhang X et al (2022a) Rapid spread of severe fever with thrombocytopenia syndrome virus by parthenogenetic Asian longhorned ticks. Emerg Infect Dis 28:363","journal-title":"Emerg Infect Dis"},{"key":"4787_CR150","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s40121-022-00693-x","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Huang Y, Xu Y (2022b) Antiviral treatment options for severe fever with thrombocytopenia syndrome infections. Infect Dis Ther 11:1805\u20131819","journal-title":"Infect Dis Ther"},{"key":"4787_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02285-2","volume":"21","author":"S-S Zhang","year":"2024","unstructured":"Zhang S-S et al (2024a) Metabolic alterations in urine among the patients with severe fever with thrombocytopenia syndrome. Virol J 21:11. https:\/\/doi.org\/10.1186\/s12985-024-02285-2","journal-title":"Virol J"},{"key":"4787_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012068","volume":"18","author":"S Zhang","year":"2024","unstructured":"Zhang S et al (2024b) Association of liver function and prognosis in patients with severe fever with thrombocytopenia syndrome. PLoS Negl Trop Dis 18:e0012068. https:\/\/doi.org\/10.1371\/journal.pntd.0012068","journal-title":"PLoS Negl Trop Dis"},{"key":"4787_CR153","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00829-24","volume":"12","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yan L-n, Liu B-y, Zhou C-m, Yu X-j (2024c) The hnRNP A2B1 is important for the replication of SFTSV and other RNA viruses. Microbiol Spectr 12:e00829-00824 https:\/\/doi.org\/10.1128\/spectrum.00829-24","journal-title":"Microbiol Spectr"},{"key":"4787_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-024-02150-x","volume":"20","author":"Z Zhang","year":"2024","unstructured":"Zhang Z et al (2024d) Differential short-term and long-term metabolic and cytokine responses to infection of severe fever with thrombocytopenia syndrome virus. Metabolomics 20:84. https:\/\/doi.org\/10.1007\/s11306-024-02150-x","journal-title":"Metabolomics"},{"key":"4787_CR155","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314747121","volume":"121","author":"G Zhao","year":"2024","unstructured":"Zhao G et al (2024) Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery. Proc Natl Acad Sci U S A 121:e2314747121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4787_CR156","volume":"12","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Wu X, Wang X, Li L (2025) Evolving therapeutic strategies for severe fever with thrombocytopenia syndrome: from past to future. Ther Adv Infect Dis 12:20499361251340786","journal-title":"Ther Adv Infect Dis"},{"key":"4787_CR157","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1038\/s41564-024-01801-y","volume":"9","author":"X Zheng","year":"2024","unstructured":"Zheng X et al (2024) Taurolithocholic acid protects against viral haemorrhagic fever via inhibition of ferroptosis. Nat Microbiol 9:2583\u20132599. https:\/\/doi.org\/10.1038\/s41564-024-01801-y","journal-title":"Nat Microbiol"},{"key":"4787_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676861","author":"C-m Zhou","year":"2021","unstructured":"Zhou C-m, Yu X-j (2021) Unraveling the underlying interaction mechanism between Dabie bandavirus and innate immune response. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.676861","journal-title":"Front Immunol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04787-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:09:36Z","timestamp":1779797376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04787-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":158,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4787"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04787-9","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have consented to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"231"}}